Summary
The blood chemistry and clinical pharmacokinetics of thioridazine and its metabolites, side-chain sulphoxide, side-chain sulphone and ring sulphoxide, were studied in 31 alcoholics and were compared with values in 17 thioridazine-treated controls without alcoholism. Pathological blood chemistry values, including abnormal liver function and protein concentrations, were common among the alcoholics. In relation to dosage, the majority had a low serum concentration of thioridazine and at a given concentration of thioridazine they had high serum concentrations of its metabolites. Positive intercorrelations were found between pathological liver function tests, prolonged serum half-life and increased serum concentration of thioridazine. The free fractions of thioridazine, side-chain sulphoxide and ring sulphoxide were significantly higher and those of the side-chain sulphone lower in the alcoholics than in the controls. The free fractions of side-chain and ring sulphoxide were significantly increased in patients with a low concentration of α1-acid glycoprotein.
Similar content being viewed by others
References
Axelsson R, Mårtensson E (1976) Serum concentration and elimination from serum of thioridazine in psychiatric patients. Curr Ther Res 19: 242–265
Spitzer RL (1980) Diagnostic and statistical manual of mental disorders. 3rd ed. (DSM III). American Psychiatric Association, New York
Mårtensson E, Nyberg G, Axelsson R (1975) Quantitative determination of thioridazine and nonconjugated thioridazine metabolites in serum and urine of psychiatric patients. Curr Ther Res 18: 687–700
Nyberg G, Axelsson R, Mårtensson E (1978) Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients. Eur J Clin Pharmacol 14: 341–350
Bradley JV (1968) Distribution-free statistical tests. Prentice-Hall, London
Mantel N (1963) Chi-square test with one degree of freedom; extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 58: 690–695
Odén A, Wedel H (1975) Arguments for Fisher's permutation test. Ann Stat 3: 518–522
Axelsson R, Mårtensson E (1977) The concentration pattern of nonconjugated thioridazine metabolites in serum by thioridazine treatment and its relationship to physiological and clinical variables. Curr Ther Res 21: 561–586
Piafsky K, Borgå O (1977) Plasma protein binding of basic drugs (II). Importance of α1-acid glycoprotein for interindividual variation. Clin Pharmacol Ther 22: 545–549
Axelsson R, Mårtensson E (1980) Side effects of thioridazine and their relationship with the serum concentrations of the drug and its main metabolites. Curr Ther Res 28: 463–489
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Axelsson, R., Mårtensson, E. & Alling, C. Serum concentration and protein binding of thioridazine and its metabolites in patients with chronic alcoholism. Eur J Clin Pharmacol 23, 359–363 (1982). https://doi.org/10.1007/BF00613621
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00613621